The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs
MetadataShow full item record
Copyright © Cambridge University Press 2016.Although high hepatitis C virus (HCV) prevalence has been observed in people who inject drugs (PWID) for decades, research suggests incidence is falling. We examined whether PWIDs' use of opioid substitution therapy (OST) and their needle-and-syringe sharing behaviour explained HCV incidence. We assessed HCV incidence in 235 PWID in Melbourne, Australia, and performed discrete-time survival with needle-sharing and OST status as independent variables. HCV infection, reinfection and combined infection/reinfection incidences were 7.6 [95% confidence interval (CI) 4.8-11.9], 12.4 (95% CI 9.1-17.0) and 9.7 (95% CI 7.4-12.6) per 100 person-years, respectively. Needle-sharing was significantly associated with higher incidence of naive HCV infection [hazard ratio (HR) 4.9, 95% CI 1.3-17.7] but not reinfection (HR 1.85, 95% CI 0.79-4.32); however, a cross-model test suggested this difference was sample specific. Past month use of OST had non-significant protective effects against naive HCV infection and reinfection. Our data confirm previous evidence of greatly reduced HCV incidence in PWID, but not the significant protective effect of OST on HCV incidence detected in recent studies. Our findings reinforce the need for greater access to HCV testing and prevention services to accelerate the decline in incidence, and HCV treatment, management and support to limit reinfection.
Showing items related by title, author, creator and subject.
High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort StudySacks-Davis, R.; Aitken, C.; Higgs, Peter; Spelman, T.; Pedrana, A.; Bowden, S.; Bharadwaj, M.; Nivarthi, U.; Suppiah, V.; George, J.; Grebely, J.; Drummer, H.; Hellard, M. (2013)Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible ...
Hellard, M.; McBryde, E.; Sacks Davis, R.; Rolls, D.; Higgs, Peter; Aitken, C.; Thompson, A.; Doyle, J.; Pattison, P.; Robins, G. (2015)Background: The hepatitis C virus (HCV) epidemic is a major health issue; in most developed countries it is driven by people who inject drugs (PWID). Injecting networks powerfully influence HCV transmission. In this paper ...
Hellard, M.; McBryde, E.; Sacks Davis, R.; Rolls, D.; Higgs, Peter; Aitken, C.; Thompson, A.; Doyle, J.; Pattison, P.; Robins, G. (2015)© 2015 Elsevier B.V. Background: The hepatitis C virus (HCV) epidemic is a major health issue; in most developed countries it is driven by people who inject drugs (PWID). Injecting networks powerfully influence HCV ...